Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783650 · ClinicalTrials.gov registry record · NA
Boosting Primary Care Awareness and Treatment of Childhood Hypertension
A NA study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03783650: Clinical Trial NA study, sponsored by Montefiore Medical Center.
NCT03783650 is a NA study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03783650, a NA study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The proposed research, building on an ongoing AHRQ-funded research project to prevent pediatric diagnostic errors in primary care (R01HS023608) and using a prospective, cluster-randomized, stepped wedge design, will investigate whether 1) a quality improvement collaborative (QIC) intervention without subspecialist involvement, 2) a QIC with subspecialists and primary care physicians (PCPs) mutually engaged, and/or 3) a hub and spoke co-diagnosis, co-management model where PCPs diagnose and manage pediatric hypertension (HTN) with a supporting subspecialist advisor, reduce errors in pediatric HTN diagnosis and management compared to each other and usual care.
Primary Outcome
Number of patients without all correct diagnostic and management decisions per 100 patients with measured elevated BP
Interventions
- BEHAVIORAL Control condition
- BEHAVIORAL QIC with PCP and without subspecialist
- BEHAVIORAL QIC with Subspecialist
- BEHAVIORAL Hub and Spoke co-management
- BEHAVIORAL Sustainability of changes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-07-14 |
| Phase | NA |
Why NCT03783650 stopped before completion
NCT03783650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 5 interventions - of which Control condition is the first listed.
NCT03783650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03783650 about?
NCT03783650 is a clinical study titled "Boosting Primary Care Awareness and Treatment of Childhood Hypertension". The proposed research, building on an ongoing AHRQ-funded research project to prevent pediatric diagnostic errors in primary care (R01HS023608) and using a prospective, cluster-randomized, stepped wedge design, will investigate whether 1) a quality improvement collaborative (QIC) intervention withou...
What is the current status of trial NCT03783650?
This trial is currently terminated. It is a NA study. The enrollment target is 64 participants. The study started on 2018-09-01. Estimated completion is 2020-07-14.
What interventions are being tested in trial NCT03783650?
The interventions under investigation include: Control condition (BEHAVIORAL), QIC with PCP and without subspecialist (BEHAVIORAL), QIC with Subspecialist (BEHAVIORAL), Hub and Spoke co-management (BEHAVIORAL), Sustainability of changes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03783650?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03783650's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI